Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and Treatment Patterns in Celiac Disease

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Celiac disease (CD) is an immune-mediated gastrointestinal (GI) disorder driven by innate and adaptive immune responses to gluten. Presentation of CD has changed over time, with non-GI symptoms, such as anemia and osteoporosis, presenting more commonly. With improved screening and diagnostic methods, the reported prevalence of CD has increased globally, and there is considerable global variation in diagnostic and treatment practices. The objective of this study was to describe the current state of CD diagnosis and treatment patterns. A targeted review of literature from MEDLINE, Embase, the Cochrane Library, and screening of relevant conference abstracts was performed. The generally recommended diagnostic approach is GI endoscopy with small bowel biopsy; however, in selected patients, biopsy may be avoided and diagnosis based on positive serology and clinical symptoms. Diagnosis often is delayed; the average diagnostic delay after symptom onset is highly variable and can last up to 12 years. Barriers to accurate and timely diagnosis include atypical presentation, lack of physician awareness about current diagnostic criteria, misdiagnosis, and limited access to specialists. Currently, strict adherence to a gluten-free diet (GFD) is the only recommended treatment, which is not successful in all patients. Only one-third of patients are monitored regularly following diagnosis. Unmet needs for CD include improvements in the accuracy and timeliness of diagnosis, and the development of treatments for both refractory CD and GFD nonresponsive CD. Further research should investigate the impact of education about gluten-free eating and the availability of gluten-free foods support adherence and improve outcomes in patients with CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.

    Article  PubMed  Google Scholar 

  2. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tonutti E, Bizzaro N. Diagnosis and classification of celiac disease and gluten sensitivity. Autoimmun Rev. 2014;13:472–476.

    Article  CAS  PubMed  Google Scholar 

  4. Ludvigsson JF, Rubio-Tapia A, van Dyke CT, et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenterol. 2013;108:818–824.

    Article  PubMed  PubMed Central  Google Scholar 

  5. West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109:757–768.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Zingone F, West J, Auricchio R, et al. Incidence and distribution of coeliac disease in Campania (Italy): 2011–2013. U Eur Gastroenterol J. 2015;3:182–189.

    Article  Google Scholar 

  7. Kang JY, Kang AH, Green A, Gwee KA, Ho KY. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–245.

    Article  CAS  PubMed  Google Scholar 

  8. Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135:1099–1106.

    Article  CAS  PubMed  Google Scholar 

  9. Guandalini S, Assiri A, Author A, et al. Celiac disease: a review. JAMA Pediatr. 2014;168:272–278.

    Article  PubMed  Google Scholar 

  10. Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128:S74–S78.

    Article  PubMed  Google Scholar 

  11. Lionetti E, Catassi C. The role of environmental factors in the development of celiac disease: what is new? Diseases. 2015;3:282–293.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.

    Article  PubMed  Google Scholar 

  13. Reilly NR, Hammer ML, Ludvigsson JF, et al. Transition of care in celiac disease: adolescent to adult care. Gluten intake is common, and follow up is poor. Gastroenterology. 2016;150:S12.

    Article  Google Scholar 

  14. Green PH, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96:126–131; Myths about coeliac disease, https://www.coeliac.org.uk/coeliac-disease/myths-about-coeliac-disease/.

  15. Pulido O, Zarkadas M, Dubois S, et al. Clinical features and symptom recovery on a gluten-free diet in Canadian adults with celiac disease. Can J Gastroenterol. 2013;27:449–453.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007;102:1454–1460.

    Article  PubMed  Google Scholar 

  17. Ludvigsson JF, Card TR, Kaukinen K, et al. Screening for celiac disease in the general population and in high-risk groups. U Eur Gastroenterol J. 2015;3:106–120.

    Article  Google Scholar 

  18. Iskandar H, Gray DM, Vu H, et al. Coeliac disease screening is suboptimal in a tertiary gastroenterology setting. Postgrad Med J. 2017;93:472–475.

    Article  CAS  PubMed  Google Scholar 

  19. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520.

    Article  PubMed  Google Scholar 

  20. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. 2010;123:691–693.

    Article  PubMed  Google Scholar 

  21. Husby S, Koletzko S, Korponay-Szabo IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.

    Article  CAS  PubMed  Google Scholar 

  22. Bebb J, Lawson A, Knight T, Long R. Long-term follow-up of coeliac disease—what do coeliac patients want? Aliment Pharmacol Ther. 2006;23:827–831.

    Article  CAS  PubMed  Google Scholar 

  23. Silvester JA, Rashid M. Long-term management of patients with celiac disease: current practices of gastroenterologists in Canada. Can J Gastroenterol Hepatol. 2010;24:499–509.

    Google Scholar 

  24. Eigner W, Bashir K, Primas C, et al. Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years. Aliment Pharmacol Ther. 2016;45:364.

    Article  PubMed  Google Scholar 

  25. Rostami-Nejad M, Villanacci V, Hogg-Kollars S, et al. Endoscopic and histological pitfalls in the diagnosis of celiac disease: a multicentre study assessing the current practice. Rev esp de Enferm Dig. 2013;105:326–333.

    Article  Google Scholar 

  26. Nurminen S, Kivela L, Huhtala H, Kaukinen K, Kurppa K. Extraintestinal manifestations were common in children with coeliac disease and were more prevalent in patients with more severe clinical and histological presentation. Acta Paediatr. 2018. https://doi.org/10.1111/apa.14324.

    Article  PubMed  Google Scholar 

  27. Tapsas D, Hollen E, Stenhammar L, Falth-Magnusson K. The clinical presentation of coeliac disease in 1030 Swedish children: changing features over the past four decades. Dig Liver Dis. 2016;48:16–22.

    Article  PubMed  Google Scholar 

  28. Mooney PD, Evans KE, Singh S, Sanders DS. Treatment failure in coeliac disease: a practical guide to investigation and treatment of non-responsive and refractory coeliac disease. J Gastrointest Liver Dis. 2012;21:197–203.

    Google Scholar 

  29. O’Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671–680.

    Article  PubMed  Google Scholar 

  30. Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445–450.

    Article  PubMed  Google Scholar 

  31. Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016–2021.

    Article  PubMed  Google Scholar 

  32. de Lourdes Moreno M, Cebolla Á, Muñoz-Suano A, et al. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut. 2017;66:250–257.

    Article  CAS  Google Scholar 

  33. Comino I, Fernandez-Banares F, Esteve M, et al. Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients. Am J Gastroenterol. 2016;111:1456–1465. https://doi.org/10.1038/ajg.2016.1439. Epub 2016 Sep 1420.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Losurdo G, Marra A, Shahini E, et al. Small intestinal bacterial overgrowth and celiac disease: a systematic review with pooled-data analysis. Neurogastroenterol Motil. 2017;29:13028.

    Article  Google Scholar 

  35. Ilus T, Kaukinen K, Virta LJ, et al. Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease. Aliment Pharmacol Ther. 2014;39:418–425.

    Article  CAS  PubMed  Google Scholar 

  36. Roshan B, Leffler DA, Jamma S, et al. The incidence and clinical spectrum of refractory celiac disease in a North American referral center. Am J Gastroenterol. 2011;106:923–928.

    Article  PubMed  Google Scholar 

  37. Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136:81–90.

    Article  PubMed  Google Scholar 

  38. Rubio-Tapia A, Malamut G, Verbeek WH, et al. Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther. 2016;44:704–714.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Rubio-Tapia A, Kelly DG, Lahr BD, Dogan A, Wu TT, Murray JA. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology. 2009;136:99–107.

    Article  PubMed  Google Scholar 

  40. Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol. 2010;7:204–213.

    Article  CAS  PubMed  Google Scholar 

  41. Robson K, Alizart M, Martin J, Nagel R. Coeliac patients are undiagnosed at routine upper endoscopy. PLoS ONE. 2014;9:e90552.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Choung RS, Unalp-Arida A, Ruhl CE, Brantner TL, Everhart JE, Murray JA. Less hidden celiac disease but increased gluten avoidance without a diagnosis in the United States: findings from the national health and nutrition examination surveys from 2009 to 2014. In: Mayo Clinic proceedings;2016.

  43. Choung RS, Larson SA, Khaleghi S, et al. Prevalence and morbidity of undiagnosed celiac disease from a community-based study. Gastroenterology. 2017;152:e835.

    Google Scholar 

  44. Gonzalez DA, de Armas LG, Rodriguez IM, et al. Strategies to improve the efficiency of celiac disease diagnosis in the laboratory. J Immunol Methods. 2017;449:62–67.

    Article  CAS  PubMed  Google Scholar 

  45. Kurppa K, Ashorn M, Iltanen S, et al. Celiac disease without villous atrophy in children: a prospective study. J Pediatr. 2010;157:373–380.

    Article  PubMed  Google Scholar 

  46. Chou R, Bougatsos C, Blazina I, Mackey K, Grusing S, Selph S. Screening for celiac disease: evidence report and systematic review for the US preventive services task force. JAMA. 2017;317:1258–1268.

    Article  PubMed  Google Scholar 

  47. Paul SP, Harries SL, Basude D. Barriers to implementing the revised ESPGHAN guidelines for coeliac disease in children: a cross-sectional survey of coeliac screen reporting in laboratories in England. Arch Dis Child. 2017;102:942–946.

    Article  PubMed  Google Scholar 

  48. Robert ME, Crowe SE, Burgart L, et al. Statement on best practices in the use of pathology as a diagnostic tool for celiac disease: a guide for clinicians and pathologists. Am J Surg Pathol. 2018;42:e44–e58.

    Article  PubMed  Google Scholar 

  49. Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol Rep (Oxf). 2015;3:3–11.

    Article  Google Scholar 

  50. Vaquero L, Rodriguez-Martin L, Alvarez-Cuenllas B, et al. Coeliac disease and gastrointestinal symptom screening in adult first-degree relatives. J Gastroenterol Hepatol. 2017;32:1931–1937.

    Article  CAS  PubMed  Google Scholar 

  51. Holmes GKT, Forsyth JM, Knowles S, Seddon H, Hill PG, Austin AS. Coeliac disease: further evidence that biopsy is not always necessary for diagnosis. Eur J Gastroenterol Hepatol. 2017;29:640–645.

    Article  PubMed  Google Scholar 

  52. Niveloni S, Sugai E, Cabanne A, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem. 2007;53:2186–2192.

    Article  CAS  PubMed  Google Scholar 

  53. Sugai E, Hwang HJ, Vázquez H, et al. New serology assays can detect gluten sensitivity among enteropathy patients seronegative for anti-tissue transglutaminase. Clin Chem. 2010;56:661–665.

    Article  CAS  PubMed  Google Scholar 

  54. Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Ström M. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? Dig Dis Sci. 1996;41:83–87. https://doi.org/10.1007/BF02208588

    Article  CAS  PubMed  Google Scholar 

  55. Galatola M, Cielo D, Panico C, et al. Presymptomatic diagnosis of celiac disease in predisposed children: the role of gene expression profile. J Pediatr Gastroenterol Nutr. 2017;65:314–320.

    Article  PubMed  Google Scholar 

  56. Nakazawa H, Makishima H, Ito T, et al. Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. Int J Med Sci. 2014;11:819–823.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Ianiro G, Bibbo S, Bruno G, et al. Prior misdiagnosis of celiac disease is common among patients referred to a tertiary care center: a prospective cohort study. Clin Transl Gastroenterol. 2016;7:e139.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Fortunato F, Martinelli D, Cozza V, et al. Italian family paediatricians’ approach and management of celiac disease: a cross-sectional study in Puglia Region 2012. BMC Gastroenterol. 2014;14:38.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Wallach T, Genta RM, Lebwohl B, Green PHR, Reilly NR. Adherence to celiac disease and eosinophilic esophagitis biopsy guidelines is poor in children. J Pediatr Gastroenterol Nutr. 2017;65:64–68.

    Article  PubMed  Google Scholar 

  60. Hughey JJ, Ray BK, Lee AR, Voorhees KN, Kelly CP, Schuppan D. Self-reported dietary adherence, disease-specific symptoms, and quality of life are associated with healthcare provider follow-up in celiac disease. BMC Gastroenterol. 2017;17:156.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Arguelles-Grande C, Tennyson CA, Lewis SK, Green PH, Bhagat G. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol. 2012;65:242–247.

    Article  PubMed  Google Scholar 

  62. Marietta EV, Cartee A, Rishi A, Murray JA. Drug-induced enteropathy. Dig Dis. 2015;33:215–220.

    Article  PubMed  Google Scholar 

  63. Pallav K, Leffler DA, Tariq S, et al. Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther. 2012;35:380–390.

    Article  CAS  PubMed  Google Scholar 

  64. Shah VH, Rotterdam H, Kotler DP, Fasano A, Green PH. All that scallops is not celiac disease. Gastrointest Endosc. 2000;51:717–720.

    Article  CAS  PubMed  Google Scholar 

  65. Ierardi E, Losurdo G, Iannone A, et al. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored? Ann Gastroenterol. 2017;30:380–392.

    PubMed  PubMed Central  Google Scholar 

  66. Aziz I, Key T, Goodwin JG, Sanders DS. Predictors for celiac disease in adult cases of duodenal intraepithelial lymphocytosis. J Clin Gastroenterol. 2015;49:477–482.

    CAS  PubMed  Google Scholar 

  67. Spencer M, Lenhart A, Baker J, et al. Primary care physicians are under-testing for celiac disease in patients with iron deficiency anemia: results of a national survey. PLoS ONE. 2017;12:e0184754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Paez MA, Gramelspacher AM, Sinacore J, Winterfield L, Venu M. Delay in diagnosis of celiac disease in patients without gastrointestinal complaints. Am J Med. 2017;130:1318–1323.

    Article  PubMed  Google Scholar 

  69. Vavricka SR, Vadasz N, Stotz M, et al. Celiac disease diagnosis still significantly delayed—doctor’s but not patients’ delay responsive for the increased total delay in women. Dig Liver Dis. 2016;48:1148–1154.

    Article  PubMed  Google Scholar 

  70. Fuchs V, Kurppa K, Huhtala H, Collin P, Maki M, Kaukinen K. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49:1304–1310.

    Article  PubMed  Google Scholar 

  71. Nasr I, Campling H, Ciclitira PJ. Approach to patients with refractory coeliac disease. F1000Res. 2016;5:225.

    Article  CAS  Google Scholar 

  72. Leffler DA, Edwards George JB, Dennis M, Cook EF, Schuppan D, Kelly CP. A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease. Aliment Pharmacol Ther. 2007;26:1227–1235.

    Article  CAS  PubMed  Google Scholar 

  73. Newnham ED, Shepherd SJ, Strauss BJ, Hosking P, Gibson PR. Adherence to the gluten-free diet can achieve the therapeutic goals in almost all patients with coeliac disease: a 5-year longitudinal study from diagnosis. J Gastroenterol Hepatol. 2016;31:342–349.

    Article  CAS  PubMed  Google Scholar 

  74. Barratt SM, Leeds JS, Sanders DS. Factors influencing the type, timing and severity of symptomatic responses to dietary gluten in patients with biopsy-proven coeliac disease. J Gastrointestin Liver Dis. 2013;22:391–396.

    PubMed  Google Scholar 

  75. Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol. 2012;11:e351.

    Google Scholar 

  76. Orlando SB, Ferretti F, Bravo M, et al. Adherence to the gluten-free diet in celiac disease: a 30 year follow-up study. Dig Liver Dis. 2018;50:e233–e234.

    Google Scholar 

  77. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2009;30:315–330. https://doi.org/10.1007/s10620-018-4936-4

    Article  CAS  PubMed  Google Scholar 

  78. Shah S, Akbari M, Vanga R, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109:1304–1311.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Villafuerte-Galvez J, Vanga RR, Dennis M, et al. Factors governing long-term adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2015;42:753–760.

    Article  CAS  PubMed  Google Scholar 

  80. Charalampopoulos D, Panayiotou J, Chouliaras G, Zellos A, Kyritsi E, Roma E. Determinants of adherence to gluten-free diet in Greek children with coeliac disease: a cross-sectional study. Eur J Clin Nutr. 2013;67:615–619.

    Article  CAS  PubMed  Google Scholar 

  81. Hommel KA, Mackner LM, Denson LA, Crandall WV. Treatment regimen adherence in pediatric gastroenterology. J Pediatr Gastroenterol Nutr. 2008;47:526–543.

    Article  PubMed  PubMed Central  Google Scholar 

  82. MacCulloch K, Rashid M. Factors affecting adherence to a gluten-free diet in children with celiac disease. Paediatr Child Health. 2014;19:305–309.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Muhammad H, Reeves S, Ishaq S, Mayberry J, Jeanes YM. Adherence to a gluten free diet is associated with receiving gluten free foods on prescription and understanding food labelling. Nutrients. 2017;9:705.

    Article  PubMed Central  Google Scholar 

  84. Martin U, Mercer SW. A comparison of general practitioners prescribing of gluten-free foods for the treatment of coeliac disease with national prescribing guidelines. J Hum Nutr Diet. 2014;27:96–104.

    Article  CAS  PubMed  Google Scholar 

  85. Malamut G, Cellier C. Refractory celiac disease: epidemiology and clinical manifestations. Dig Dis (Basel, Switzerland). 2015;33:221–226.

    Article  Google Scholar 

  86. Nasr I, Nasr I, Beyers C, Chang F, Donnelly S, Ciclitira PJ. Recognising and managing refractory coeliac disease: a tertiary centre experience. Nutrients. 2015;7:9896–9907.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Rowinski SA, Christensen E. Epidemiologic and therapeutic aspects of refractory coeliac disease—a systematic review. Dan Med J. 2016;63:1–6.

    Google Scholar 

  88. Rubio-Tapia A, Barton SH, Murray JA. Celiac disease and persistent symptoms. Clin Gastroenterol Hepatol. 2011;9:13–17.

    Article  PubMed  Google Scholar 

  89. Cellier C, Bouma G, van Gils T, et al. 616-AMG 714 (Anti-IL-15 MAB) halts the progression of aberrant intraepithelial lymphocytes in refractory celiac disease type II (RCD-II): a phase 2A, randomized, double-blind, placebo-controlled study evaluating AMG 714 in adult patients with RCD-II/pre-EATL. Gastroenterology. 2018;154:S-129–S-130.

    Article  Google Scholar 

  90. Wungjiranirun M, Kelly CP, Leffler DA. Current status of celiac disease drug development. Am J Gastroenterol. 2016;111:779–786.

    Article  CAS  PubMed  Google Scholar 

  91. Marino M, Casale R, Borghini R, et al. The effects of modified versus unmodified wheat gluten administration in patients with celiac disease. Int Immunopharmacol. 2017;47:1–8.

    Article  CAS  PubMed  Google Scholar 

  92. James SP. National institutes of health consensus development conference statement on celiac disease, June 28–30, 2004. Gastroenterology. 2005;128:S1.

    Article  Google Scholar 

  93. Rostom A, Murray JA, Kagnoff MF. American gastroenterological association (AGA) institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.

    Article  PubMed  Google Scholar 

  94. Herman ML, Rubio-Tapia A, Lahr BD, Larson JJ, Dyke CTV, Murray JA. Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol. 2012;10:e891.

    Article  Google Scholar 

  95. Greuter T, Schoepfer AM, Frei P, et al. Substantial proportion of celiac disease patients is misleadingly diagnosed based on serology only-diagnostic and therapeutic experience from a reallife setting in Switzerland. United Eur Gastroenterol J. 2015;3:A679.

    Google Scholar 

  96. Virta LJ, Saarinen MM, Kolho KL. Declining trend in the incidence of biopsy-verified coeliac disease in the adult population of Finland, 2005–2014. Aliment Pharmacol Ther. 2017;46:1085–1093.

    Article  CAS  PubMed  Google Scholar 

  97. Tortora R, Zingone F, Rispo A, et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol. 2016;51:1179–1183.

    Article  CAS  PubMed  Google Scholar 

  98. Vavricka S, Schoepfer A, Frei P, et al. The diagnostic delay in celiac disease is significantly increased in women due to doctor’s but not patient’s delay. United Eur Gastroenterol J. 2015;3:A500.

    Google Scholar 

  99. DeGaetani M, Tennyson CA, Lebwohl B, et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol. 2013;108:647–653.

    Article  CAS  PubMed  Google Scholar 

  100. Leffler DA, Dennis M, Edwards George JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:530–536.

    Article  PubMed  Google Scholar 

  101. van Hees NJ, Van der Does W, Giltay EJ. Coeliac disease, diet adherence and depressive symptoms. Rheumatol (Oxford). 2013;52:939–943. https://doi.org/10.1093/rheumatology/kes1390. Epub 2013 Jan 1018.

    Article  Google Scholar 

  102. Hall NJ, Rubin GP, Charnock A. Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey. Appetite. 2013;68:56–62.

    Article  PubMed  Google Scholar 

  103. Wolf RL, Lebwohl B, Lee AR, et al. Hypervigilance to a gluten-free diet and decreased quality of life in teenagers and adults with celiac disease. Dig Dis Sci. 2018;63:1438. https://doi.org/10.1007/s10620-018-4936-4

    Article  PubMed  Google Scholar 

  104. van den Broeck HC, van Herpen TW, Fau-Schuit C, Schuit C, Fau-Salentijn EMJ, et al. Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines. BMC Plant Biol. 2009;9:41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Kelly CP, Green PH, Murray JA, et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther. 2013;37:252–262.

    Article  CAS  PubMed  Google Scholar 

  106. Leffler DA, Kelly CP, Abdallah HZ, et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol. 2012;107:1554–1562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Giacomin P, Zakrzewski M, Croese J, et al. Experimental hookworm infection and escalating gluten challenges are associated with increased microbial richness in celiac subjects. Sci Rep. 2015;5:13797.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Kowalski K, Mulak A, Jasinska M, Paradowski L. Diagnostic challenges in celiac disease. Adv Clin Exp Med. 2017;26:729–737.

    Article  PubMed  Google Scholar 

  109. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391:70–81.

    Article  PubMed  Google Scholar 

  110. Walker MM, Ludvigsson JF, Sanders DS. Coeliac disease: review of diagnosis and management. Med J Aust. 2017;207:173–178.

    Article  PubMed  Google Scholar 

  111. Al-Bawardy B, Codipilly DC, Rubio-Tapia A, Bruining DH, Hansel SL, Murray JA. Celiac disease: a clinical review. Abdom Radiol (NY). 2017;42:351–360.

    Article  Google Scholar 

  112. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–354.

    Article  CAS  PubMed  Google Scholar 

  113. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–1194.

    Article  CAS  PubMed  Google Scholar 

  114. Corazza GR, Villanacci V, Zambelli C, et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol. 2007;5:838–843.

    Article  PubMed  Google Scholar 

  115. Naiyer AJ, Hernandez L, Ciaccio EJ, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol. 2009;43:225–232.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Truven Health Analytics, an IBM Company, received a research contract from Takeda Pharmaceuticals International Co. to conduct the study and prepare this manuscript.

Author information

Authors and Affiliations

  1. IBM Watson Health, 75 Binney Street, Cambridge, MA, 02142, USA

    Allie B. Cichewicz, Elizabeth S. Mearns, Talia Boulanger & Kelly J. Thomas Craig

  2. Takeda Development Centre Europe, 61 Aldwych, London, WC2B 4AE, UK

    Aliki Taylor

  3. Takeda Pharmaceuticals International Co, 35 Landsdowne Street, Cambridge, MA, 02139, USA

    Michele Gerber, Daniel A. Leffler & Jennifer Drahos

  4. Royal Hallamshire Hospital and University of Sheffield, Glossop Road, Sheffield, S10 2FJ, UK

    David S. Sanders

  5. Department of Medicine, Celiac Disease Centre, Columbia University Medical Center, 180 Fort Washington Avenue, Suite 936, New York, NY, 10032, USA

    Benjamin Lebwohl

Authors
  1. Allie B. Cichewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth S. Mearns
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aliki Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Talia Boulanger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michele Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel A. Leffler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jennifer Drahos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. David S. Sanders
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kelly J. Thomas Craig
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Benjamin Lebwohl
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The guarantor of article: Allie Cichewicz, MS. ESM, AT, TB, MG, JD, DSS, DAL, and BL contributed to the concept and design of the literature review. ESM and ABC performed the research and collected and analyzed the data. ESM, TB, ABC, and KJC wrote the paper. All authors provided critical analyses of the manuscript drafts and approved the final version of the article.

Corresponding author

Correspondence to Elizabeth S. Mearns.

Ethics declarations

Conflict of interest

ESM, TB, ABC, and KJC are or were employees of Truven Health Analytics, an IBM Company, during the completion of this study. AT, MG, JD, and DAL are or were employed by Takeda Pharmaceuticals International Co. BL and DSS serve as consultants for Takeda Pharmaceuticals International Co. No authors have any conflicts of interest germane to this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 31 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cichewicz, A.B., Mearns, E.S., Taylor, A. et al. Diagnosis and Treatment Patterns in Celiac Disease. Dig Dis Sci 64, 2095–2106 (2019). https://doi.org/10.1007/s10620-019-05528-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05528-3

Keywords

Search

Navigation